Diagnosis and Outcomes of Late‐Onset Wilson's Disease: A National Registry‐Based Study

Archive ouverte

Nilles, Christelle | Obadia, Mickael Alexandre | Sobesky, Rodolphe | Dumortier, Jérôme | Guillaud, Olivier | Laurencin, Chloé | Moreau, Caroline | Vanlemmens, Claire | Ory-Magne, Fabienne | de Ledinghen, Victor | Bardou-Jacquet, Edouard | Fluchère, Frederique | Collet, Corinne | Oussedik-Djebrani, Nouzha | Woimant, France | Poujois, Aurélia

Edité par CCSD ; Wiley -

International audience. Abstract Background Wilson's disease (WD) is usually diagnosed in children and young adults; limited data exist on late‐onset forms. Objective The aim was to characterize the clinical and paraclinical presentations, therapeutic management, and outcomes in patients with late‐onset WD. Methods Patients diagnosed with WD after age 40 years were identified from the French Wilson's Disease Registry (FWDR). Clinical, laboratory, and imaging findings and treatment were reported at diagnosis and last follow‐up. Results Forty‐five patients were identified (median age: 49, range: 40–64) and placed in three groups according to their clinical presentation: neurological (n = 20, median diagnostic delay: 20 months), hepatic (n = 13, diagnostic delay: 12 months), and family screening (n = 12), all confirmed genetically. Six neurological patients had an atypical presentation (1 torticollis, 2 writer's cramps, 2 functional movement disorders, and 1 isolated dysarthria), without T2/fluid‐attenuated inversion recovery brain magnetic resonance imaging (MRI) hyperintensities; 5 of 6 had no Kayser–Fleischer ring (KFR); 5 of 6 had liver involvement. In the neurological group, 84% of patients improved clinically, and 1 developed copper deficiency. In the hepatic group, 77% had cirrhosis; 6 patients required liver transplantation. In the screened group, 43% had mild liver involvement; 3 were not treated and remained stable; 24‐h urinary copper excretion was normal in 33% of patients at diagnosis. Conclusions In the FWDR, late‐onset forms of WD affect 8% of patients, mostly with neurological presentations. Thirty percent of the neurological forms were atypical (isolated long‐lasting symptoms, inconspicuous brain MRI, no KFR). With personalized treatment, prognosis was good. This study emphasized that WD should be suspected at any age and even in cases of atypical presentation. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Consulter en ligne

Suggestions

Du même auteur

Maintenance therapy simplification using a single daily dose: A preliminary real-life feasibility study in patients with Wilson disease

Archive ouverte | Guillaud, Olivier | CCSD

International audience

Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients

Archive ouverte | Laurencin, Chloé | CCSD

International audience. Background: The aim of this work is to report our early experiences about the benefits of liver transplantation (LT) in the treatment of persistent neurological symptoms in Wilson's disease (...

Long term results of liver transplantation for Wilson's disease: experience in France

Archive ouverte | Guillaud, Olivier | CCSD

International audience. BACKGROUND & AIMS: Liver transplantation (LT) is the therapeutic option for severe complications of Wilson's disease (WD). We aimed to report on the long-term outcome of WD patients following...

Chargement des enrichissements...